Clifford Chance has advised Heilpflanzenwohl AG on the deal. Heilpflanzenwohl AG finalized the acquisition of two OTC products, “Döderlein” and “Omniflora”, from Haleon Sarl. The project...
You must be a Standard 1 Year member to access this content.
On the deal, Clifford Chance and Mourant advised CBC Group and Mubadala; Cleary Gottlieb acted as onshore legal advisors to Mubadala. CBC Group, Asia’s largest healthcare-dedicated...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Keymed Biosciences (Chengdu) Co., Ltd. on the deal. Keymed Biosciences (Chengdu) Co., Ltd. completed an out-licensing transaction with Belenos Biosciences, Inc.to exclusively...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Hitachi Ltd. on the deal. Hitachi Ltd. has signed a stock purchase agreement to acquire all shares of MA micro automation GmbH from...
You must be a Standard 1 Year member to access this content.
PXR and Clifford Chance advised Sanity Group on the deal. Hogan Lovells advised British American Tobacco Group. Sanity Group announced its €37.6 million Series B financing round. The...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Neuraxpharm Group on the deal. Neuraxpharm Group acquired two portfolios of established products from Sanofi which are marketed globally in more than...
You must be a Standard 1 Year member to access this content.
